Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Applied and Environmental Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mycology

Farnesol Concentrations Required To Block Germ Tube Formation in Candida albicans in the Presence and Absence of Serum

Daniel D. Mosel, Raluca Dumitru, Jacob M. Hornby, Audrey L. Atkin, Kenneth W. Nickerson
Daniel D. Mosel
School of Biological Sciences, University of Nebraska, Lincoln, Nebraska 68588-0666
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raluca Dumitru
School of Biological Sciences, University of Nebraska, Lincoln, Nebraska 68588-0666
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob M. Hornby
School of Biological Sciences, University of Nebraska, Lincoln, Nebraska 68588-0666
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey L. Atkin
School of Biological Sciences, University of Nebraska, Lincoln, Nebraska 68588-0666
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth W. Nickerson
School of Biological Sciences, University of Nebraska, Lincoln, Nebraska 68588-0666
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: knickerson1@unl.edu
DOI: 10.1128/AEM.71.8.4938-4940.2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Concentrations of (E,E)-farnesol needed to inhibit germ tube formation were determined for Candida albicans strains A72 and SC5314 by using six different conditions known to trigger germination. For defined media, 1 to 2 μM farnesol was sufficient. However, with serum at 2 to 20%, up to 250 μM farnesol was required. Farnesol blocked germ tube formation but did not block elongation of existing germ tubes.

Fungal yeast-mycelium dimorphism is of interest because of the economic and medical importance of dimorphic fungi and because these organisms may serve as model systems for studying differentiation. Farnesol is a fungal quorum-sensing molecule with intriguing regulatory properties in Candida albicans (7). This compound is excreted continuously by C. albicans (7), and when it accumulates beyond a threshold level, it blocks the yeast-to-mycelium conversion (7). Farnesol blocks mycelial development initiated by any of three chemically distinct triggers for germ tube formation: l-proline, N-acetylglucosamine, and serum (7). Of these, serum (10 to 20% [vol/vol] at 37°C) has been used most commonly (9, 15). Serum has even been described as the “magic potion” for the induction of germ tubes by C. albicans (5). Thus, both farnesol's mode of action and the therapeutic potential of farnesol analogs are of interest.

By stationary phase, 2 to 4 μM farnesol, which is at a concentration well above the 1.2 μM concentration needed to block germ tube formation in an N-acetylglucosamine-stimulated differentiation assay (17), has accumulated in cultures of C. albicans (7, 8). However, some recent studies (10, 11, 16, 18, 19) with farnesol and C. albicans have used farnesol concentrations (250 to 500 μM) that we believe are much higher than those that are physiologically relevant. Farnesol is a lipophilic molecule that can accumulate in membranes, and the farnesol effects observed at these concentrations may be nonspecific. In some cases, these higher concentrations may result in physiological artifacts. Indeed, Kim et al. (10) found that 450 μM farnesol inhibited growth of C. albicans by 35%.

Our objectives in this study were threefold: (i) to identify the minimum levels of farnesol needed to block germ tube formation in six media commonly used to trigger germination; (ii) to establish the physiological relevance of the production levels we have observed, 2 to 4 μM farnesol (7, 8); and (iii) to test our hypothesis that much higher levels of farnesol are needed to block germ tube formation in serum. This hypothesis was developed because of the presence of albumins in serum; albumins are noted for their nonspecific lipid binding capacity (20).

Procedures for the growth and storage of C. albicans were as described previously (7, 8, 17). Strain A72 is also ATCC MYA-2430. Strain SC5314 was used for the genomic sequence for C. albicans (www.candidagenome.org ). (E,E)-Farnesol (Sigma Chemical, St. Louis, MO) was freshly prepared as a stock solution (10 mM) in methanol and stored under nitrogen to prevent oxidation (17).

All resting cell preparations were washed three times in 50 mM potassium phosphate buffer (pH 6.5) prior to use. Resting cells were inoculated into 5 ml of prewarmed (37°C) medium at a cell density of 2 × 107 per ml and incubated in 25-ml flasks at 37°C with aeration by shaking at 200 rpm on a G2 shaker (New Brunswick Scientific Co., Edison, NJ). Samples were removed periodically for microscopic examination.

The liquid media used were (i) 2.5 mM N-acetylglucosamine with imidazole and magnesium (7), (ii) glucose phosphate proline (GPP) (7, 12), (iii) Lee's medium (13), (iv) yeast nitrogen base without amino acids but supplemented with 2.5 mM N-acetylglucosamine (1), (v) RPMI 1640 (1) (Invitrogen), and (vi) serum (2 to 20%) in distilled, deionized water. Pig, horse, sheep, and bovine sera were obtained from the Meat Animal Research Center, Clay Center, Nebr. The solid medium used was GPP with 1.5% agar. After being autoclaved, the molten medium was cooled to 45°C and then added to 100- by 15-mm plastic petri dishes (20 ml medium/dish) containing appropriate aliquots of farnesol. The dishes were swirled to mix the farnesol into the medium before the agar solidified. Because the 20 ml per petri dish was estimated by eye, the resulting farnesol concentrations also differ somewhat. We believe the medium volumes are accurate to ±1 ml, and thus, the farnesol concentrations would be accurate to ±5%. Germ tube formation was quantified on plates by using a Labophot-2 microscope (Nikon Inc. Instrument Group, Melville, NY) modified as a tetrad dissection microscope (Micro Video Instruments, Avon, MA) using a Plan 10/0.30 objective lens.

Farnesol concentrations with and without serum.

Control cultures with no farnesol always had 98 to 100% germ tubes. For each of the defined media, the level of farnesol needed to reduce germ tube formation to 50% was ∼1 μM for both strains of C. albicans (Table 1). Also, the levels of farnesol needed were the same for liquid and solid GPP media (Table 1); they were not influenced by the presence of agar. However, the farnesol levels needed were influenced dramatically by the presence of serum. Serum increased the amount of farnesol needed in a dose-dependent manner (Table 1), which reached 150 to 250 μM farnesol at 10 to 20% serum. Virtually identical results were obtained with pig serum, horse serum, sheep serum, and bovine serum (Table 1).

View this table:
  • View inline
  • View popup
TABLE 1.

Concentration of farnesol needed to reduce germ tube formation to 50%

Commitment.

We also sought to clarify the effect of farnesol on preexisting hyphae (Fig. 1). Germ tube formation was blocked completely when farnesol was added at any time up to 30 min after inoculation. However, it was not blocked at all when the farnesol was added 90 min after inoculation, and it was stopped at an intermediate value (ca. 60% germ tubes) when the farnesol was added 60 min after inoculation (Fig. 1). These experiments were done with both strain A72 and strain SC5314 in both the N-acetylglucosamine differentiation medium and the GPP growth medium. The data shown in Fig. 1 are for SC5314 in GPP. In all cases, farnesol blocked germ tube formation by cells that did not already have visible germ tubes. These cells formed buds instead. However, farnesol neither reversed nor altered germ tube formation by cells that already had visible germ tubes. Those cells were committed to mycelial development (2, 14). Thus, farnesol does not halt the growth or elongation of existing mycelia, even at concentrations as high as 50 μM. When farnesol was added 2 hours after the inoculation of C. albicans A72 in N-acetylglucosamine, the germ tubes continued to elongate for at least the next 3.5 hours (6). Ramage et al. (16) reported a similar phenomenon during biofilm formation by C. albicans. Once hyphal formation had been initiated, it was not inhibited by the addition of farnesol (16). The present work extends their finding to include other, nonbiofilm germ tube-forming conditions.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Kinetics of germ tube formation (GTF) with farnesol added at various time points. C. albicans SC5314 was grown in GPP medium at 37°C, and farnesol (30 μM) was added at time zero (▪), 30 min (•), 60 min (▴), and 90 min (⧫). X, no farnesol addition. Values shown are the averages of duplicate measurements conducted on separate days which agreed within ±5%. The values for the samples with farnesol added at 90 min were the same as those with no farnesol addition.

The disparity in farnesol concentrations needed with and without serum (Table 1) is consistent with our hypothesis on the farnesol binding capacity of serum albumins. Albumins play an important role in the transport of sparingly soluble metabolic products from one tissue to another (20). Substances such as dyes, fatty acids, bilirubin, sulfonamides, and naphthoquinone derivatives, all of which are sparingly soluble in water, are readily dissolved in albumin solutions (20), and in each instance, it has been demonstrated that the dissolved substance is actually bound to the protein (20). Farnesol is also sparingly soluble in water (7). These differences with and without serum further illustrate the advantages of working with chemically defined media. Moreover, the fatty acid binding abilities of serum albumins can be exploited; adding fatty acid-deficient bovine serum albumin (0.4%) is a common mechanism for avoiding the toxic effects of excess fatty acids. The added albumins create a slow-release fatty acid buffer (3). We expect that the influences of farnesol on cell morphology will differ greatly during pathogenesis depending on location within the body. Two relevant factors would be the presence of albumins and the degree of anaerobicity, since C. albicans does not excrete farnesol under strictly anaerobic conditions (4).

ACKNOWLEDGMENTS

This work was supported by grants from the National Science Foundation (MCB-0110999) and the University of Nebraska Tobacco Settlement Biomedical Research Enhancement Fund. D. D. Mosel, an undergraduate student at Nebraska Wesleyan University, Lincoln, was supported by a grant from the Howard Hughes Medical Institute to Nebraska Wesleyan University.

We thank Susan Hassler and Joe Ford, Meat Animal Research Center, Clay Center, Nebr., for providing the serum samples.

FOOTNOTES

    • Received 5 February 2005.
    • Accepted 11 March 2005.
  • Copyright © 2005 American Society for Microbiology

REFERENCES

  1. 1.↵
    Atlas, R. M. 1993. Handbook of microbiological media. CRC Press, Boca Raton, Fla.
  2. 2.↵
    Chaffin, W. L., and D. E. Wheeler. 1981. Morphological commitment in Candida albicans. Can. J. Microbiol.27:131-137.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Das, D. V. M., and G. Weeks. 1979. Effects of polyunsaturated fatty acids on the growth and differentiation of the cellular slime mould, Dictyostelium discoideum. Exp. Cell Res.118:237-243.
    OpenUrlPubMed
  4. 4.↵
    Dumitru, R., J. M. Hornby, and K. W. Nickerson. 2004. Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs. Antimicrob. Agents Chemother.48:2350-2354.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Ernst, J. F. 2000. Transcription factors in Candida albicans—environmental control of morphogenesis. Microbiology146:1763-1774.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Hornby, J. M. 2003. Quorum sensing and the regulation of morphology in the dimorphic fungus Candida albicans. Ph.D. thesis. University of Nebraska—Lincoln, Lincoln.
  7. 7.↵
    Hornby, J. M., E. C. Jensen, A. D. Lisec, J. J. Tasto, B. Jahnke, R. Shoemaker, P. Dussault, and K. W. Nickerson. 2001. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl. Environ. Microbiol.67:2982-2992.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Hornby, J. M., and K. W. Nickerson. 2004. Enhanced production of farnesol by Candida albicans treated with four azoles. Antimicrob. Agents Chemother.48:2305-2307.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Hudson, D. A., Q. L. Sciascia, R. J. Sanders, G. E. Norris, P. J. B. Edwards, P. A. Sullivan, and P. C. Farley. 2004. Identification of the dialyzable serum inducer of germ-tube formation in Candida albicans. Microbiology150:3041-3049.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    Kim, S., E. Kim, D.-S. Shin, H. Kang, and K.-B. Oh. 2002. Evaluation of morphogenic regulatory activity of farnesoic acid and its derivatives against Candida albicans dimorphism. Bioorg. Med. Chem. Lett.12:895-898.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Kruppa, M., B. P. Krom, N. Chauchan, A. V. Bambach, R. L. Cihlar, and R. A. Calderone. 2004. The two-component signal transduction protein Chk1p regulates quorum sensing in Candida albicans. Eukaryot. Cell3:1062-1065.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Kulkarni, R. K., and K. W. Nickerson. 1981. Nutritional control of dimorphism in Ceratocystis ulmi. Exp. Mycol.5:148-154.
    OpenUrlCrossRef
  13. 13.↵
    Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia13:148-153.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Mitchell, L. H., and D. R. Soll. 1979. Commitment to germ tube or bud formation during release from stationary phase in Candida albicans. Exp. Cell Res.120:167-179.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Odds, F. C. 1988. Candida and candidosis, 2nd ed. Bailliere Tindall, London, United Kingdom.
  16. 16.↵
    Ramage, G., S. P. Saville. B. L. Wickes, and J. L. Lopez-Ribot. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol.68:5459-5463.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Schepin, R., J. M. Hornby, E. Burger, T. Niessen, P. Dussault, and K. W. Nickerson. 2003. Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs. Chem. Biol.10:743-750.
    OpenUrlCrossRefPubMed
  18. 18.↵
    Soto, T., T. Watanabe, T. Mikami, and T. Matsumoto. 2004. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade. Biol. Pharm. Bull.27:751-752.
    OpenUrlCrossRefPubMed
  19. 19.↵
    Uppuluri, P., and L. Chaffin. 2004. Effect of farnesol on expression of Candida albicans stationary phase genes SNO1 and SNZ1. Abstr. 7th Am. Soc. Microbiol. Candida Candidiasis Conf., Austin, Tex., abstr. 243.
  20. 20.↵
    White, A., P. Handler, and E. L. Smith. 1959. Principles of biochemistry, 3rd ed. McGraw-Hill, New York, N.Y.
PreviousNext
Back to top
Download PDF
Citation Tools
Farnesol Concentrations Required To Block Germ Tube Formation in Candida albicans in the Presence and Absence of Serum
Daniel D. Mosel, Raluca Dumitru, Jacob M. Hornby, Audrey L. Atkin, Kenneth W. Nickerson
Applied and Environmental Microbiology Aug 2005, 71 (8) 4938-4940; DOI: 10.1128/AEM.71.8.4938-4940.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Applied and Environmental Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Farnesol Concentrations Required To Block Germ Tube Formation in Candida albicans in the Presence and Absence of Serum
(Your Name) has forwarded a page to you from Applied and Environmental Microbiology
(Your Name) thought you would be interested in this article in Applied and Environmental Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Farnesol Concentrations Required To Block Germ Tube Formation in Candida albicans in the Presence and Absence of Serum
Daniel D. Mosel, Raluca Dumitru, Jacob M. Hornby, Audrey L. Atkin, Kenneth W. Nickerson
Applied and Environmental Microbiology Aug 2005, 71 (8) 4938-4940; DOI: 10.1128/AEM.71.8.4938-4940.2005
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • Farnesol concentrations with and without serum.
    • Commitment.
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Candida albicans
Farnesol
Serum

Related Articles

Cited By...

About

  • About AEM
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AppEnvMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

 

Print ISSN: 0099-2240; Online ISSN: 1098-5336